Drug Profile
NIP 530
Latest Information Update: 05 Apr 2001
Price :
$50
*
At a glance
- Originator Nissan Chemical Industries
- Class Antihistamines; Benzimidazoles
- Mechanism of Action Histamine H1 receptor antagonists; Neurokinin 1 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Atopic dermatitis
Most Recent Events
- 05 Apr 2001 Discontinued-Preclinical for Atopic dermatitis in Japan (Unknown route)
- 14 Sep 1999 New profile
- 14 Sep 1999 Preclinical development for Atopic dermatitis in Japan (Unknown route)